Study of new ICU atrial fibrillation
Part of Heart & circulation clinical trials.
This trial looks at people who develop a new irregular heart rhythm called atrial fibrillation while in the intensive care unit (ICU). It tests an approach to help with that condition after critical illness, aiming to improve outcomes for those affected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have new atrial fibrillation that started in the ICU (not a past history)
- Your ICU stay included breathing support through a breathing tube and/or medicines that raise blood pressure or support the heart
- Have a way to legally join the study (consent) and be covered by the national social security system
- Not have been in certain situations that exclude you, like heart rhythm history or being in another conflicting trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often atrial fibrillation (an irregular heartbeat) comes back after a person develops it for the first time during an ICU stay. You may be followed long-term to understand recurrence and better plan future care.
This trial studies abnormal electrical signals in the right upper heart chamber and how they relate to atrial fibrillation (AF). It may help improve how doctors target AF treatment during catheter ablation for people who have AF symptoms.
This trial tests whether giving magnesium can lower the chance of developing new irregular heartbeat (atrial fibrillation) in critically ill adults in the ICU. If you are at risk but do not already have this rhythm issue, magnesium may help prevent it.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study watches how people recover from a recent stroke caused by a heart rhythm problem called atrial fibrillation (or AFib). It aims to find better ways to predict recovery and guide future care.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.